![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Articles
Driving Patient Engagement in Alzheimer’s Disease Clinical Research to Achieve Trial Success
Worldwide, around 47 million people have dementia, and there are 9.9 million new cases every year, according to recent data from the World Health...
Articles
Solving Challenges and Pain Points for Complex Global Clinical Trials
Clinical trials are evolving away from trials based solely at investigator sites, moving on to the patient’s home, requiring direct-to-patient services in order for...
Articles
The Importance of the Human Touch in Improving Clinical Trial Patient-Centricity
Patient-centricity has become an important focus for drug developers and an essential element of clinical studies aimed at showing that a new therapy addresses...
Clinical Trials
Cmed to Demonstrate the Capture, Visualization and RTA of Clinical Data using encapsia® at Mobile in Clinical Trials and DPharm 2017
Cmed has announced it will present its encapsia® clinical data suite at Mobile in Clinical Trials and DPharm: Disruptive Innovations to Advance Clinical Trials...
Clinical Trials
Initiation of Cytisine Clinical Development Program Announced By Achieve
Achieve Life Sciences, Inc. a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced initiation of...
Clinical Trials
BioSight Completed Patient Enrollment and Treatment in its Extended Acute Leukemia Phase I/II Clinical Trial
BioSight, Ltd, a pharmaceutical development company, focused on the development of targeted oncology therapeutics with reduced toxicity, announced completion of last patient treatment in...
Clinical Trials
Randomization In Phase 2/3 Trial In Spinocerebellar Ataxia Completed By Biohaven
Biohaven Pharmaceutical Holding Company Ltd. announced today that it has commenced dosing of all 141 randomized patients with spinocerebellar ataxia (SCA)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read